S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

NMRA Neumora Therapeutics Inc

12.92

-0.16 (-1.22%)

Sep 27 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Neumora Therapeutics (NASDAQ:NMRA)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Neumora Therapeutics Charts.

Neumora Therapeutics (NASDAQ:NMRA)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Neumora Therapeutics Charts.

Neumora Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 19 September 2024 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 18 September 2024 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 17 September 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 16 September 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 12 September 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 August 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 August 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 22 August 2024 (1 month ago) • Edgar (US Regulatory)

Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders
Wednesday 14 August 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)

Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Tuesday 6 August 2024 (2 months ago) • GlobeNewswire Inc.

More Neumora Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions